Lord, Abbett & Co’s Halozyme HALO Stock Holding History

Lord, Abbett & Co’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-340,686	Closed	-$15M	–	586
2022 Q2	$15M	Buy	+340,686	New	+$14.7M	0.05%	359

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co's HALO Position: Q3 2022 in Review

Lord, Abbett & Co sold out of Halozyme (HALO) in Q3 2022, closing a stake of 340,686 shares — an estimated $15M sold.

Lord, Abbett & Co first reported a position in HALO in Q2 2022 and held it in 1 quarter. The position peaked at $15M in Q2 2022. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

Lord, Abbett & Co reported no remaining Halozyme position as of Q3 2022 after selling out during the quarter.
Lord, Abbett & Co sold 340,686 Halozyme shares in Q3 2022, an estimated $15M.
Lord, Abbett & Co first reported a position in Halozyme in Q2 2022 and held it in 1 quarter.
Lord, Abbett & Co's Halozyme position peaked at $15M in Q2 2022.
357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on Lord, Abbett & Co's 13F filing for Q3 2022, filed 14 Nov 2022.